Jeong Nayoung, Kim Yejee, Kim Chungjong, Park Sangmin, Lee Joongyub, Choi Namkyong
Department of Health Convergence, Ewha Womans University, Seoul 03760, Korea.
Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
Vaccines (Basel). 2021 Jul 6;9(7):746. doi: 10.3390/vaccines9070746.
Previous studies have shown controversial results on the risk of Bell's palsy after influenza vaccination. Since the antigenic components of influenza vaccine can vary from season to season, continuous safety monitoring is required. The aim of the present study was to determine whether there was an increased risk of Bell's palsy in the elderly after influenza vaccination between the 2015/2016 and 2017/2018 flu seasons. This study included the elderly who received influenza vaccinations for three flu seasons using a large-linked database of vaccination registration data from the Korea Disease Control and Prevention Agency and the National Health Insurance Service claims data. We used a self-controlled risk interval design with a risk interval of 1 to 42 days and a control interval of 57 to 98 days postvaccination and calculated the incidence rate ratio. To ensure the robustness of the results, sensitivity analyses were also carried out with different risk and control intervals. Of 4,653,440 elderly people who received the influenza vaccine, there was no statistically significant increase in the risk of Bell's palsy (IRR: 0.99, 95% CI: 0.92-1.07). Similar results were found in analysis results for each season and the results of the sensitivity analyses excluding the 2017/2018 season. In conclusion, we found no evidence of an increased risk of Bell's palsy after influenza vaccination. The results of our study provide reassurance about the safety of the influenza vaccine NIP program. However, it is necessary to continuously monitor the risk of Bell's palsy during future flu seasons.
先前的研究在流感疫苗接种后贝尔麻痹风险方面呈现出有争议的结果。由于流感疫苗的抗原成分可能随季节变化,因此需要持续进行安全性监测。本研究的目的是确定在2015/2016年和2017/2018年流感季节之间,老年人接种流感疫苗后贝尔麻痹风险是否增加。本研究纳入了使用韩国疾病控制与预防机构的疫苗接种登记数据大链接数据库以及国民健康保险服务理赔数据,连续三个流感季节接种流感疫苗的老年人。我们采用自我对照风险区间设计,风险区间为接种后1至42天,对照区间为接种后57至98天,并计算发病率比。为确保结果的稳健性,还采用不同的风险和对照区间进行了敏感性分析。在4653440名接种流感疫苗的老年人中,贝尔麻痹风险没有统计学上的显著增加(发病率比:0.99,95%置信区间:0.92 - 1.07)。在各季节的分析结果以及排除2017/2018季节后的敏感性分析结果中也发现了类似结果。总之,我们没有发现流感疫苗接种后贝尔麻痹风险增加的证据。我们的研究结果为流感疫苗国家免疫规划项目的安全性提供了 reassurance 。然而,在未来流感季节持续监测贝尔麻痹风险是必要的。